Back to search

University of Ioannina

Η έκφραση του OCT-4 και DAZL στις καλοήθειες παθήσεις του μαστού και σε καρκίνο του μαστού

Abstract

dc:description

Purpose:This study aims to detect the presence and expression of the Oct-4 and Dazl genes in benign diseases and cancerous breast tumors using two different laboratory methods. It also aims to determine the diagnostic value of anti-Müllerian hormone AMH in relation to 5-year recurrence-free and metastases-free survival after surgical removal.Material – Method:The study population consisted of 18 patients who had undergone radical modified or simple mastectomy surgery after a diagnosis of benign disease or breast cancer. For the detection and quantification of the Oct-4 and Dazl genes, both the Real-time qPCR technique with the LightCycler 480 machine and the immunohistochemistry technique using the Benchmark ULTRA VENTANA machine, where an automatic staining technique is performed, were performed. Finally, the hormonal determination of the AMH of the samples was done using the AMH Gen II Elisa.Results:The expression of both genes was negative by immunohistochemistry. Contrasted with the real-time polymerase chain reaction method all samples showed positive expression of the Oct-4 gene and 4 of 13 for the Dazl gene. 83% of the women in the study survived five years after surgical removal without developing any disease recurrence or cancer metastases, and during that time they had low levels of anti-Müllerian hormone in their blood serum.Conclusions:The present work showed that the results of the two laboratory methods aimed at determining the expression of the Oct-4 and Dazl genes in samples of benign diseases and breast cancer do not agree with each other. However, real-time qPCR detected a barely detectable expression of the Dazl gene and demonstrated a higher expression of the Oct-4 gene in grade 2 invasive lobular carcinoma samples compared to fibroadenomas and non-invasive lobular carcinomas and higher than 67 % of specimens involving invasive serous carcinomas. We therefore conclude that the Oct-4 gene is more expressed in cancer cells and mainly in glandular lobes than in breast ducts, suggesting that cancer cells, as they divide uncontrollably, may use the undifferentiated phenotype characteristic of stem cells, as a result of functional cooperation of Oct-4, Sox2 and Nanog.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Plakas, Georgios
  • Πλάκας, Γεώργιος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53957

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Plakas, Georgios; Πλάκας, Γεώργιος. Η έκφραση του OCT-4 και DAZL στις καλοήθειες παθήσεις του μαστού και σε καρκίνο του μαστού. University of Ioannina, 2023. http://hdl.handle.net/10442/hedi/53957